| News

Basel gains new biotech in Bright Peak

30.07.2020

Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech. It will operate in Basel and San Diego.

Versant Ventures, a healthcare venture capital firm from Silicon Valley with an office in Basel, launched Bright Peak Therapeutics. Bright Peak will operate across sites in Basel and San Diego. The internal research and development team is based in Basel. They will be working alongside a founding team of leading scientists who, according to a press release, have made major contributions to the fields of protein engineering.

Bright Peaks, a developer of next-generation protein therapeutics, will be receiving seed capital of US$35 million from Versant Ventures. The biotech company has a portfolio of designer cytokines with the potential to be advanced as novel immune-oncology therapeutics. This pipeline was developed within Versant’s Ridgeline laboratories in collaboration with the Swiss Federal Institute of Technology in Zurich (ETH).

Bright Peak’s technology platform has been licensed by ETH. It allows a wide range of proteins to be chemically assembled de novo in order to optimize their function.

Bright Peak’s chemistry know-how originated in the laboratory of co-founder Jeffrey Bode, professor of organic chemistry at ETH and a leader in the chemical synthesis of proteins. The fact this technology is “delivering substantial quantities of precisely tailored proteins” is gratifying, said Bode: “I look forward to exploring the breadth of this approach with the team at Bright Peak.”

Versant has recruited “industry veteran” Sef Kurstjens to join as Bright Peak president and CEO. Alongside Bode, the company’s scientific founders and advisors include John Teijaro, associate professor in the department of immunology and microbiology at the Scripps Research Institute, and Dr Markus Enzelberger, partner at Versant since 2002 and recognized as an “authority in the field of protein engineering”.

With Versant’s anchor investment, the company plans to expand its 20-member team to more than 30 scientists this year and expects to advance its lead program into clinical testing in 2021. Bright Peak will also pursue Pharma partners in parallel with financial investors over the coming months.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Botanikind settles in Basel
Basel Area Business & Innovation, Innovation, Invest

Botanikind settles in Basel

The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for...

Read More
Kinarus secures capital commitment of 57 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Kinarus secures capital commitment of 57 million Swiss francs

The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group...

Read More
Biotech startups from the Basel Area confirm leading position
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Biotech startups from the Basel Area confirm leading position

As part of the Top 100 Swiss Startup Awards 2021, the most promising startups in Switzerland are honored. These also...

Read More
T3 Pharma wins Swiss Economic Award
Basel Area Business & Innovation, Innovation, Invest

T3 Pharma wins Swiss Economic Award

T3 Pharma has won the Swiss Economic Award 2021. Switzerland’s most prestigious young entrepreneur prize is awarded by the Swiss...

Read More
Worg selects Basel Area for European headquarters
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Worg selects Basel Area for European headquarters

Worg Pharmaceuticals has opted to establish its European headquarters at the site Allschwil of the Switzerland Innovation Park Basel Area....

Read More
ten23 health settles in Basel
Basel Area Business & Innovation, Innovation, Invest

ten23 health settles in Basel

The life sciences cluster Rosental Mitte located in Basel is home to a new, globally active company called ten23 health....

Read More
1 2 3 48

Do you have a question? We'd like to hear from you.